Publication:
Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus

Loading...
Thumbnail Image

Date

2018-01-01

Authors

Kilicarslan, Rukiye
Cakirca, MUSTAFA
Aydin, SİNEM
OZKAN, Tuba
KOCAMAN, Orhan
Yolbas, Servet
Zorlu, MEHMET
Karatoprak, CUMALİ
Kiskac, MUHARREM
CIKRIKCIOGLU, Mehmet Ali

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.

Description

Keywords

Citation

Karatoprak C., Kilicarslan R., Cakirca M., Aydin S., OZKAN T., KOCAMAN O., Yolbas S., Zorlu M., Kiskac M., CIKRIKCIOGLU M. A. , et al., -Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus-, BEZMIALEM SCIENCE, cilt.6, ss.1-5, 2018
Page Views

0

File Downloads

6

Sustainable Development Goals